{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:31:55Z","timestamp":1789781515575,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T00:00:00Z","timestamp":1250726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s10067-009-1251-7","type":"journal-article","created":{"date-parts":[[2009,8,18]],"date-time":"2009-08-18T20:22:42Z","timestamp":1250626962000},"page":"1379-1384","source":"Crossref","is-referenced-by-count":58,"title":["The treatment with N-acetylcysteine of Raynaud\u2019s phenomenon and ischemic ulcers therapy in sclerodermic patients: a prospective observational study of 50 patients"],"prefix":"10.1007","volume":"28","author":[{"given":"Edoardo","family":"Rosato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Borghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Pisarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Salsano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,20]]},"reference":[{"key":"1251_CR1","first-page":"202","volume":"15","author":"EC LeRoy","year":"1998","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1998) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202\u2013205","journal-title":"J Rheumatol"},{"key":"1251_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbspin.2006.07.002","volume":"74","author":"M Gayraud","year":"2007","unstructured":"Gayraud M (2007) Raynaud\u2019s phenomenon. Jt Bone Spine 74:1\u20138","journal-title":"Jt Bone Spine"},{"key":"1251_CR3","first-page":"2423","volume":"34","author":"E Hachulla","year":"2007","unstructured":"Hachulla E, Clerson P, Launay D, Lambert M, Morell-Dubois S, Queyrel V, Hatron PY (2007) Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study. J Rheumatol 34:2423\u20132430","journal-title":"J Rheumatol"},{"key":"1251_CR4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.autrev.2006.12.006","volume":"6","author":"S Guiducci","year":"2007","unstructured":"Guiducci S, Giacomelli R, Cerinic MM (2007) Vascular complications of scleroderma. Autoimmun Rev 6:520\u2013523","journal-title":"Autoimmun Rev"},{"key":"1251_CR5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/rheumatology\/keh552","volume":"44","author":"AL Herrick","year":"2005","unstructured":"Herrick AL (2005) Pathogenesis of Raynaud\u2019s phenomenon. Rheumatology 44:587\u2013596","journal-title":"Rheumatology"},{"key":"1251_CR6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/BOR.0b013e3282f13137","volume":"19","author":"S Henness","year":"2007","unstructured":"Henness S, Wigley FM (2007) Current drug therapy for scleroderma and secondary Raynaud\u2019s phenomenon: evidence-based review. Curr Opin Rheumatol 19:611\u2013618","journal-title":"Curr Opin Rheumatol"},{"key":"1251_CR7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0049-0172(75)90017-7","volume":"4","author":"PM Campbell","year":"1975","unstructured":"Campbell PM, LeRoy EC (1975) Pathogenesis of systemic sclerosis: an vascular hypothesis. Semin Arthritis Rheum 4:351\u2013368","journal-title":"Semin Arthritis Rheum"},{"key":"1251_CR8","first-page":"314","volume":"25","author":"T Yamamoto","year":"1998","unstructured":"Yamamoto T, Katayama I, Nishioka K (1998) Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol 25:314\u2013317","journal-title":"J Rheumatol"},{"key":"1251_CR9","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","volume":"50","author":"JH Korn","year":"2004","unstructured":"Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, Rich E, Carpentier P, Molitor J, Seibold JR, Hsu V, Guillevin L, Chatterjee S, Peter HH, Coppock J, Herrick A, Merkel PA, Simms R, Denton CP, Furst D, Nguyen N, Gaitonde M, Black C (2004) Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 50:3985\u20133993","journal-title":"Arthritis Rheum"},{"key":"1251_CR10","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.10486","volume":"46","author":"PA Merkel","year":"2002","unstructured":"Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsger TA Jr, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jim\u00e9nez SA, White B, Seibold JR, Wigley FM, Scleroderma Clinical Trials Consortium (2002) Measuring disease activity and functional status in patients with scleroderma and Raynaud\u2019s phenomenon. Arthritis Rheum 46:2410\u20132420","journal-title":"Arthritis Rheum"},{"key":"1251_CR11","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1164\/ajrccm.156.6.9706065","volume":"156","author":"J Behr","year":"1997","unstructured":"Behr J, Maier K, Degenkolb B, Krombach F, Vogelmeier C (1997) Antioxidative and clinical effects of high-dose n-acetylcysteine in fibrosing alveolitis: adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 156:1897\u20131901","journal-title":"Am J Respir Crit Care Med"},{"key":"1251_CR12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0167-5273(92)90063-9","volume":"35","author":"J Sochman","year":"1992","unstructured":"Sochman J, Peregrin JH (1992) Total recovery of left ventricular function after acute myocardial infarction: comprehensive therapy with streptokinase, N-acetylcysteine and percutaneous transluminal coronary angioplasty. Int J Cardiol 35:116\u2013118","journal-title":"Int J Cardiol"},{"key":"1251_CR13","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1097\/01.hjh.0000249705.42230.73","volume":"24","author":"N Tian","year":"2006","unstructured":"Tian N, Rose RA, Jordan S, Dwyer TM, Hughson MD, Manning RD Jr (2006) N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension. J Hypertens 24:2263\u20132270","journal-title":"J Hypertens"},{"key":"1251_CR14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000106103","volume":"25","author":"G Sahin","year":"2007","unstructured":"Sahin G, Yalcin AU, Akcar N (2007) Effect of N-acetylcysteine on endothelial dysfunction in dialysis patients. Blood Purif 25:309\u2013315","journal-title":"Blood Purif"},{"key":"1251_CR15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.ASN.0000107562.68920.92","volume":"15","author":"S Fishbane","year":"2004","unstructured":"Fishbane S, Durham JH, Marzo K, Rudnick M (2004) N-Acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 15:251\u2013260","journal-title":"J Am Soc Nephrol"},{"key":"1251_CR16","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMoa042976","volume":"353","author":"M Demedts","year":"2005","unstructured":"Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CDR, Capron F, Petruzzelli S, De Vuyst P, van den Bosch JMM, Rodriguez-Becerra E, Corvasce G, Lankhorst I, Sardina M, Montanari M (2005) High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353:2229\u20132242","journal-title":"N Engl J Med"},{"key":"1251_CR17","first-page":"2257","volume":"28","author":"P Sambo","year":"2001","unstructured":"Sambo P, Amico D, Giacomelli R, Matucci-Cerinic M, Salsano F, Valentini G, Gabrielli A (2001) Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study. J Rheumatol 28:2257\u20132262","journal-title":"J Rheumatol"},{"key":"1251_CR18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/039463200501800420","volume":"18","author":"F Salsano","year":"2005","unstructured":"Salsano F, Letizia C, Proietti M, Rossi C, Proietti AR, Rosato E, Pisarri S (2005) Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-acetylcysteine long term treatment of patients with sclerodermic Raynaud\u2019s phenomenon. Int J Immunopathol Pharmacol 18:761\u2013770","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1251_CR19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","unstructured":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581\u2013590","journal-title":"Arthritis Rheum"},{"key":"1251_CR20","first-page":"1407","volume":"19","author":"FM Wigley","year":"1992","unstructured":"Wigley FM, Seibold JR, Wise RA, McCloskey DA, Dole WP (1992) Intravenous iloprost treatment of Raynaud\u2019s phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol 19:1407\u20131414","journal-title":"J Rheumatol"},{"key":"1251_CR21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/039463200802100322","volume":"21","author":"A Merla","year":"2008","unstructured":"Merla A, Di Donato L, Romani GL, Proietti M, Salsano F (2008) Comparison of thermal infrared and laser doppler imaging in the assessment of cutaneous tissue perfusion in scleroderma patients and healthy controls. Int J Immunopathol Pharmacol 21:679\u2013686","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1251_CR22","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1074\/jbc.M107711200","volume":"277","author":"R Colavitti","year":"2002","unstructured":"Colavitti R, Pani G, Bedogni B, Anzevino R, Borrello S, Waltenberger J, Galeotti T (2002) Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2\/KDR. J Biol Chem 277:3101\u20133108","journal-title":"J Biol Chem"},{"key":"1251_CR23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1440-1843.2009.01511.x","volume":"14","author":"S Cai","year":"2009","unstructured":"Cai S, Chen P, Zhang C, Chen JB, Wu J (2009) Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats. Respirology 14:354\u2013359","journal-title":"Respirology"},{"key":"1251_CR24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.mad.2008.01.004","volume":"129","author":"G Voghel","year":"2008","unstructured":"Voghel G, Thorin-Trescases N, Farhat N, Mamarbachi AM, Villeneuve L, Fortier A, Perrault LP, Carrier M, Thorin E (2008) Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients. Mech Ageing Dev 129:261\u2013270","journal-title":"Mech Ageing Dev"},{"key":"1251_CR25","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2337\/dc07-2251","volume":"31","author":"V Martina","year":"2008","unstructured":"Martina V, Masha A, Gigliardi VR, Brocato L, Manzato E, Berchio A, Massarenti P, Settanni F, Della Casa L, Bergamini S, Iannone A (2008) Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care 31:940\u2013944","journal-title":"Diabetes Care"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-009-1251-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1251-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:37Z","timestamp":1559105497000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-009-1251-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,20]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1007\/s10067-009-1251-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,20]]}}}